本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Lakewood-Amedex Biotherapeutics (Direct Listing)

2.17
+0.05002.36%
盤後2.13-0.0416-1.92%19:30 EDT
成交量:9.80萬
成交額:20.71萬
市值:514.22萬
市盈率:-0.21
高:2.17
開:2.17
低:2.07
收:2.12
52周最高:98.20
52周最低:1.66
股本:236.97萬
流通股本:141.56萬
量比:0.08
換手率:6.93%
股息:- -
股息率:- -
每股收益(TTM):-10.2000
每股收益(LYR):-8.3987
淨資產收益率:-402.84%
總資產收益率:-139.40%
市淨率:1.19
市盈率(LYR):-0.26

資料載入中...

2026/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/06

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/15

重要事件披露

Form 8-K - Current report
2026/06/23

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/17

重要事件披露

Form 8-K - Current report
2026/05/22

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/13

SEC問詢函

Form CORRESP - Correspondence
2026/05/01

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/04/29

重要事件披露

Form 8-K - Current report
2026/04/06

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/04/01

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/03/12

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/02/13

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/02/05

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/01/09

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933